• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Parity Laws and the Need for Payment Reform

Video

During this segment, Scott Gottlieb, MD; Brian Kiss, MD; Michael Kolodziej, MD; and Ted Okon, MBA, continue the discussion regarding issues that affect new oncology care models, including drug wastage, patient compliance, and treatment costs.

As more oncology drugs are being dispensed via practice-based pharmacies, intervention is needed to reduce waste, Dr Kolodziej comments. Also, compliance remains an issue even with the advent of practice-based pharmacies.

Although some states have passed parity laws, meaning that patient out-of-pocket (OOP) costs for oral medications should not be greater than OOP costs for intravenous medications, high OOP costs remain a barrier to patient access to treatment.

Dr Kiss discusses the buy-and-bill model’s impact on oncology and suggests that payment reform is necessary. Oncologists should be compensated for providing cognitive and technical services, he believes, rather than for dispensing chemotherapy drugs.


Related Videos
Dr Sheela Rao
4 experts are featured in this series.
4 experts are featured in this series.
5 experts in this video
4 experts are featured in this series.
5 experts in this video
Coral Omene, MD, PhD, sitting for a vieo interview
5 experts are featured in this series
5 experts are featured in this series
David Awad, PharmD, BCOP
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.